Abstract
Diseased-cell secreted proteins/peptides offer several leads in biomarker development. Blood is a rich and universal source of biomarkers because of its proximity to all cells in the body. However, important physiological and practical aspects need consideration before serum peptidomics is effectively applied in a clinical, and later bedside, setting.
Keywords: Serum, peptide/peptidome/peptidomics, concentration gradient, analyte/metabolite
Protein & Peptide Letters
Title: Metabolomics of Serum Peptides
Volume: 16 Issue: 5
Author(s): Rupak Doshi and Philip J.R. Day
Affiliation:
Keywords: Serum, peptide/peptidome/peptidomics, concentration gradient, analyte/metabolite
Abstract: Diseased-cell secreted proteins/peptides offer several leads in biomarker development. Blood is a rich and universal source of biomarkers because of its proximity to all cells in the body. However, important physiological and practical aspects need consideration before serum peptidomics is effectively applied in a clinical, and later bedside, setting.
Export Options
About this article
Cite this article as:
Doshi Rupak and Day J.R. Philip, Metabolomics of Serum Peptides, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167806
DOI https://dx.doi.org/10.2174/092986609788167806 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes
Current Drug Metabolism Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
Current Pharmaceutical Design Emerging Antimicrobial Applications of Nitric Oxide (NO) and NO-Releasing Materials
Anti-Infective Agents in Medicinal Chemistry Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs
Current Vascular Pharmacology An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments
Current Cardiology Reviews Can Statin be a Novel Pharmacophore for Antidiabetic Activity?
Mini-Reviews in Medicinal Chemistry Lipids and Non-Cardiac Vascular Disease: A Lecture Overview
Current Vascular Pharmacology Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study
Current Vascular Pharmacology Editorial [Hot Topic: The Evolution of Cell Therapy Towards Enhancing Vascular Regeneration in the Clinic (Guest Editors: Drew Kuraitis and Erik J. Suuronen)]
Current Vascular Pharmacology Aging and Oral Health: Effects in Hard and Soft Tissues
Current Pharmaceutical Design Curcumin: the Yellow Molecule with Pleiotropic Biological Effects
Letters in Drug Design & Discovery Drug Therapy in Brugada Syndrome
Current Drug Targets - Cardiovascular & Hematological Disorders PPARs and Diabetes-Associated Atherosclerosis
Current Pharmaceutical Design Vaccines for Patients with COPD
Recent Patents on Inflammation & Allergy Drug Discovery p66 Shc as the Engine of Vascular Aging
Current Vascular Pharmacology Editorial (A New Era for Medicinal Chemistry)
Mini-Reviews in Medicinal Chemistry Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry Modern Developments in the Spray-Drying Industries
Recent Patents on Materials Science Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry